Oncology Institute, Inc. (TOI) EPS (Basic) (2020 - 2026)
Oncology Institute's (TOI) quarterly EPS (Basic) came in at -$0.02 in Q1 2026, up 90.13% YoY from -$0.01 in Q1 2025, and up 70.43% on a QoQ basis from -$0.07 in Q4 2025.
Oncology Institute, Inc. (TOI) EPS (Basic) (2020 - 2026) Analysis & Trends
Oncology Institute (TOI) has 7 years of EPS (Basic) data on file, last reported at -$0.02 in Q1 2026.
- Quarterly EPS (Basic) rose 90.13% year-over-year to -$0.02 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.36 (up 47.96% YoY) and the FY2025 annual result came in at -$0.54, up 22.91% from the prior year.
- EPS (Basic) rose to -$0.02 in Q1 2026, from -$0.07 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.26 in Q1 2022 to a low of -$0.41 in Q1 2023.
- A 5-year average of -$0.15 and a median of -$0.15 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 540.03% — and 2026, when it jumped 90.13%.
- Tracing TOI's EPS (Basic) over 5 years: stood at -$0.15 in 2022, then plunged by 68.18% to -$0.25 in 2023, then soared by 43.27% to -$0.14 in 2024, then surged by 51.78% to -$0.07 in 2025, then soared by 70.43% to -$0.02 in 2026.
- The last three EPS (Basic) figures came in at -$0.02 (Q1 2026), -$0.07 (Q4 2025), and -$0.14 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.08 |
| Mar 31, 2026 | -0.02 |
| Dec 31, 2025 | -0.07 |
| Sep 30, 2025 | -0.14 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.21 |
| Dec 31, 2024 | -0.14 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.27 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.23 |
| Mar 31, 2023 | -0.41 |
| Dec 31, 2022 | -0.15 |
| Sep 30, 2022 | -0.04 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | 0.26 |
| Dec 31, 2021 | -0.15 |
| Sep 30, 2021 | -0.02 |